attention deficit hyperactivity disorder: A mental disorder characterized by inattention, easy distraction, careless mistakes and avoidance of tasks that require sustained mental focus. These behaviors can lead to maladaptive consequences in the affected individual's life.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
725 |
4. Check minimum number of eventsNone |
725 |
5. Include endpointsNone |
725 |
6. Filter based on genotype QC (FinnGen only) |
725 |
Control definitions (FinnGen only)
- Control exclude
- F5_BEHEMOCHILD
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- F90-F98
- Name in latin
- Perturbationes hyperkineticae
Similar endpoints
↥List of similar endpoints to
Hyperkinetic disorders (excl. ADHD)
based on the number of shared cases.
Similar with more cases:
- Hyperkinetic disorders
- Hyperkinetic disorders, excluding more controls
- Behavioural and emotional disorders with onset usually occurring in childhood and adolescence
- Any mental disorder
- Psychiatric diseases
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 19442 | 4593 | 14832 |
| Only index persons | 15443 | 3764 | 11679 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.35 | 0.13 | 0.41 |
| Only index persons | 0.37 | 0.14 | 0.45 |
| Median age at first event (years) | |||
| Whole population | 9.79 | 12.16 | 9.04 |
| Only index persons | 11.14 | 14.77 | 9.98 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 725 | 290 | 435 |
| Unadjusted period prevalence (%) | 0.15 | 0.10 | 0.19 |
| Median age at first event (years) | 16.59 | 24.32 | 11.44 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 647
- Matched controls
- 6412
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
F90.9
ICD-10 Finland
Hyperkinetic disorder, unspecified
1164.8
323.0
368
7
F90.0
ICD-10 Finland
Disturbance of activity and attention
131.5
323.0
388
72
N06BA04
ATC
methylphenidate; oral
99.3
312.7
334
68
F90.1
ICD-10 Finland
Hyperkinetic conduct disorder
+∞
120.3
112
*
3141A
ICD-9 Finland
Hyperkinetic syndrome of childhood, Hyperkinesis with developmental delay
+∞
103.7
97
*
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
7.9
95.3
256
491
F90.8
ICD-10 Finland
Other hyperkinetic disorders
265.2
91.8
92
*
N05AH04
ATC
quetiapine; oral
6.5
80.5
250
565
331
Kela drug reimbursment
Atomoxetine, dexamphetamine, guanfacine and lisdexamphetamine
69.4
70.1
80
13
N05AX08
ATC
risperidone; systemic
9.9
66.6
143
178
ICZ03
NOMESCO Finland
Participation in compiling a psychiatric treatment plan
9.6
60.6
132
167
F98.8
ICD-10 Finland
Other specified behavioural and emotional disorders with onset usually occurring in childhood and adolescence
214.1
57.9
59
*
ICB01
NOMESCO Finland
Psychiatric treatment plan, standard
10.7
57.5
117
130
ZY010
NOMESCO Finland
Hospital outpatient
6.6
49.5
139
255
N06AX12
ATC
bupropion; oral
7.4
49.3
127
206
Z2445
NOMESCO Finland
Psychologist
6.0
47.2
143
288
F92.9
ICD-10 Finland
Mixed disorder of conduct and emotions, unspecified
+∞
46.3
44
*
IBZ01
NOMESCO Finland
Profession-specific psychiatric evaluation
12.6
45.6
84
75
N05AH03
ATC
olanzapine; systemic
6.6
43.6
121
216
F93.89
ICD-10 Finland
Other childhood emotional disorders
98.1
42.2
46
5
F32.9
ICD-10 Finland
Depressive episode, unspecified
4.5
41.7
170
471
IBA04
NOMESCO Finland
Extensive initial psychiatric evaluation
10.9
41.0
81
83
IFA01
NOMESCO Finland
Psychiatric pharmacotherapy plan, not specified
13.0
41.0
74
63
IGY01
NOMESCO Finland
Accelerated psychiatric treatment contact
10.4
40.5
82
88
IGY99
NOMESCO Finland
Other psychiatric treatment contact
9.0
40.2
89
112
IGV01
NOMESCO Finland
Psychiatric network contact
16.2
39.1
64
43
N06BA12
ATC
lisdexamfetamine; oral
59.8
38.7
45
8
112
Kela drug reimbursment
Severe psychotic and other severe mental disorders
5.8
38.3
117
234
ZXE13
NOMESCO Finland
Procedure duration 90 to 119 minutes
6.0
37.9
113
219
N03AG01
ATC
valproic acid; systemic, rectal
6.4
37.8
106
190
IGY02
NOMESCO Finland
Psychiatric monitoring contact
7.6
37.6
92
136
F41.9
ICD-10 Finland
Anxiety disorder, unspecified
4.3
37.2
157
445
N06AB04
ATC
citalopram; systemic
4.3
36.2
152
427
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
4.6
35.9
139
361
IGP01
NOMESCO Finland
Psychiatric family contact
12.2
35.7
66
59
Z3231
NOMESCO Finland
Registered nurse
3.1
35.5
269
1209
N05BA04
ATC
oxazepam; oral
3.8
35.4
177
581
N06BA09
ATC
atomoxetine; oral
82.3
35.1
39
5
F29
ICD-10 Finland
Unspecified nonorganic psychosis
6.3
34.6
98
177
N05AX12
ATC
aripiprazole; systemic
6.3
34.3
97
175
N05BA01
ATC
diazepam; systemic, rectal
5.1
33.7
116
265
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
4.6
33.6
129
330
N06AB03
ATC
fluoxetine; oral
5.1
33.6
115
261
IEY05
NOMESCO Finland
Dedicated profession-specific psychiatric intervention, individual
6.6
33.6
91
155
ZXE05
NOMESCO Finland
Procedure duration 40 to 49 minutes
5.8
31.5
95
185
F92.8
ICD-10 Finland
Other mixed disorders of conduct and emotions
325.1
31.0
31
*
ZXE06
NOMESCO Finland
Procedure duration 50 to 59 minutes
4.9
30.8
108
250
N06AX16
ATC
venlafaxine; oral
4.0
30.6
138
409
F90
ICD-10 Finland
Hyperkinetic disorders
86.1
29.9
33
*
P29
ICPC
Psychological sympt/compl other
4.7
29.6
110
270
F93.9
ICD-10 Finland
Childhood emotional disorder, unspecified
+∞
29.3
28
*
F92.0
ICD-10 Finland
Depressive conduct disorder
+∞
29.3
28
*
Z2446
NOMESCO Finland
Social worker
3.8
29.2
140
436
T36
ICD-10 Finland
Poisoning by systemic antibiotics
6.7
29.1
77
126
R4160
NOMESCO Finland
Other therapy enhancing rehabilitation
8.9
28.8
63
77
N06AB06
ATC
sertraline; oral
4.0
28.5
128
376
F81.3
ICD-10 Finland
Mixed disorder of scholastic skills
15.9
27.6
45
30
P81
ICPC
Hyperkinetic disorder
18.5
27.3
42
24
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
5.4
27.0
86
178
ICC04
NOMESCO Finland
Psychiatric treatment plan, permanent discontinuation
7.6
27.0
65
93
F10.1
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Harmful use
5.5
26.4
82
165
IEV99
NOMESCO Finland
Other psychiatric network intervention
14.5
26.1
44
32
F81.9
ICD-10 Finland
Developmental disorder of scholastic skills, unspecified
18.3
25.9
40
23
N06AX11
ATC
mirtazapine; oral
2.9
25.9
192
816
F61.0
ICD-10 Finland
Mixed personality disorders
11.1
25.6
49
47
ZYC01
NOMESCO Finland
Remote contact by phone
5.8
25.5
75
141
F60.9
ICD-10 Finland
Personality disorder, unspecified
13.7
25.4
44
34
IFA99
NOMESCO Finland
Other psychiatric pharmacotherapy service
23.5
25.4
36
16
F84.5
ICD-10 Finland
Asperger syndrome
16.0
25.3
41
27
ICB03
NOMESCO Finland
Psychiatric treatment plan, monitoring
9.3
25.1
53
61
P99
ICPC
Psychological disorders other
8.3
24.9
56
72
IBA01
NOMESCO Finland
Diagnostic and symptom-mapping evaluation
7.6
24.6
59
84
N06AB10
ATC
escitalopram; oral
2.9
24.5
172
702
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
4.7
24.5
89
212
N03AX09
ATC
lamotrigine; oral
5.3
24.3
77
158
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
4.9
23.9
82
184
IBZ06
NOMESCO Finland
Evaluation concerning developmental neuropsychiatry
32.2
23.8
31
10
F60.30
ICD-10 Finland
Emotionally unstable personality disorder, impulsive
10.2
23.5
47
49
IAA01
NOMESCO Finland
Assessment of need for psychiatric treatment
6.2
23.2
64
111
X69
ICD-10 Finland
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
6.7
22.9
60
97
Z2221
NOMESCO Finland
Medical doctor
2.6
22.6
213
1030
ZXE02
NOMESCO Finland
Procedure duration 10 to 19 minutes
5.3
22.6
72
149
ZXY51
NOMESCO Finland
2-person team, doctor-nurse
7.7
22.5
53
73
ZXE15
NOMESCO Finland
Procedure duration 120 to 149 minutes
6.0
22.2
63
113
F91.9
ICD-10 Finland
Conduct disorder, unspecified
+∞
21.9
21
*
F83
ICD-10 Finland
Mixed specific developmental disorders
6.9
21.7
55
85
F33.9
ICD-10 Finland
Recurrent depressive disorder, unspecified
5.4
21.1
66
133
R1210
NOMESCO Finland
Medical assessment of need and possibilities to rehabilitation
12.9
21.0
37
30
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
5.2
20.9
67
139
F33.10
ICD-10 Finland
Recurrent depression, moderate episode without somatic syndrome
4.6
20.8
76
182
F41.2
ICD-10 Finland
Mixed anxiety and depressive disorder
3.2
20.3
116
405
C07AA05
ATC
propranolol; systemic
2.9
20.0
138
549
XA800
NOMESCO Finland
Neuropsychological investigation
4.1
19.9
81
215
F39
ICD-10 Finland
Unspecified mood [affective] disorder
8.9
18.8
40
47
F51.0
ICD-10 Finland
Nonorganic insomnia
3.1
18.6
112
404
N05AA02
ATC
levomepromazine; systemic
6.6
18.4
48
77
N07BB01
ATC
disulfiram; oral
5.6
18.3
54
102
Z03.2
ICD-10 Finland
Observation for suspected mental and behavioural disorders
8.4
18.1
40
50
ICB02
NOMESCO Finland
Psychiatric treatment plan, extended/prolonged
9.0
18.0
38
44
F82
ICD-10 Finland
Specific developmental disorder of motor function
7.4
18.0
43
61
F33.2
ICD-10 Finland
Recurrent depressive disorder, current episode severe without psychotic symptoms
4.8
17.7
61
137
F91.3
ICD-10 Finland
Oppositional defiant disorder
+∞
17.7
17
*
N05CF01
ATC
zopiclone; oral
2.8
17.6
125
502
F33.4
ICD-10 Finland
Recurrent depressive disorder, currently in remission
7.3
17.5
42
60
R5599
NOMESCO Finland
Other rehabilitation service
7.8
17.3
40
54
Z3226
NOMESCO Finland
Physiotherapist
2.5
17.1
158
737
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
3.2
16.9
96
334
P01
ICPC
Feeling anxious/nervous/tense
2.5
16.8
148
674
N05AN01
ATC
lithium; oral
7.9
16.7
38
50
F84.8
ICD-10 Finland
Other pervasive developmental disorders
91.7
16.6
18
*
SAA01
NOMESCO Finland
Simple examination of mouth
2.2
16.4
514
4071
F99
ICD-10 Finland
Mental disorder, not otherwise specified
6.6
16.2
42
67
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
3.1
16.1
96
344
K02.1
ICD-10 Finland
Caries of dentine
2.0
15.9
439
3266
IEP01
NOMESCO Finland
Psychoeducation, family
16.1
15.7
25
16
F81.0
ICD-10 Finland
Specific reading disorder
10.7
15.3
29
28
ZXE10
NOMESCO Finland
More than one and less than three hours
2.2
15.2
202
1117
F19.1
ICD-10 Finland
Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use
9.7
15.0
30
32
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
3.7
14.9
68
199
F60.31
ICD-10 Finland
Emotionally unstable personality disorder, borderline condition
9.4
14.7
30
33
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
3.8
14.7
63
175
IEP99
NOMESCO Finland
Other psychiatric family intervention
9.7
14.5
29
31
R1100
NOMESCO Finland
General evaluation of the need for rehabilitation
5.2
14.5
45
91
F31.8
ICD-10 Finland
Other bipolar affective disorders
7.6
14.3
33
45
F10.29
ICD-10 Finland
Addiction caused by alcohol UNS
8.6
14.1
30
36
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
2.9
14.0
91
342
N05AF03
ATC
chlorprothixene; systemic
7.1
14.0
34
50
ZXY82
NOMESCO Finland
Nurse in multidisciplinary team
10.3
14.0
27
27
N03AX16
ATC
pregabalin; oral
2.8
14.0
96
377
N05AD01
ATC
haloperidol; systemic
8.8
13.8
29
34
F13.1
ICD-10 Finland
Mental and behavioural disorders due to use of sedatives or hypnotics, harmful use
20.4
13.8
20
10
F40.1
ICD-10 Finland
Social phobias
4.5
13.6
48
111
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
3.1
13.6
79
278
N03AF02
ATC
oxcarbazepine; oral
5.3
13.5
41
81
F88
ICD-10 Finland
Other disorders of psychological development
14.1
13.2
22
16
F31.9
ICD-10 Finland
Bipolar affective disorder, unspecified
5.8
13.2
37
66
F89
ICD-10 Finland
Unspecified disorder of psychological development
40.6
13.1
16
*
F98.9
ICD-10 Finland
Unspecified behavioural and emotional disorders with onset usually occurring in childhood and adolescence
40.6
13.1
16
*
IEP03
NOMESCO Finland
Focused parental counselling
8.1
13.1
29
37
P15
ICPC
Chronic alcohol abuse
5.9
13.1
36
63
EBA00
NOMESCO Finland
Extraction of tooth
1.9
13.1
264
1701
-1
NOMESCO Finland
NA
1.9
13.1
318
2189
F81.8
ICD-10 Finland
Other developmental disorders of scholastic skills
11.2
13.0
24
22
N05AH02
ATC
clozapine; systemic
5.0
12.9
41
85
Z63.5
ICD-10 Finland
Disruption of family by separation and divorce
19.4
12.9
19
10
A02BC02
ATC
pantoprazole; systemic
1.9
12.8
253
1614
F60.3
ICD-10 Finland
Emotionally unstable personality disorder
11.8
12.8
23
20
XF400
NOMESCO Finland
ECG with 12 standard connections
2.4
12.8
116
529
F20.9
ICD-10 Finland
Schizophrenia, unspecified
6.0
12.8
35
61
R51.80
ICD-10 Finland
Headache
2.3
12.7
125
595
N06BA02
ATC
dexamfetamine; oral
70.7
12.6
14
*
R05
ICPC
Cough
2.1
12.6
172
949
P19
ICPC
Drug abuse
6.8
12.6
31
47
F91.1
ICD-10 Finland
Unsocialized conduct disorder
131.3
12.4
13
*
L17
ICPC
Foot/toe symptom/complaint
2.1
12.4
162
876
EB1AA
NOMESCO Finland
Tooth X-ray examination
1.8
12.4
335
2375
F84.9
ICD-10 Finland
Pervasive developmental disorder, unspecified
10.7
12.3
23
22
WX110
NOMESCO Finland
Local anesthesy
1.9
12.2
474
3786
N06AA12
ATC
doxepin; systemic
7.9
12.1
27
35
F34.1
ICD-10 Finland
Dysthymia
5.2
12.1
37
74
SPAT1240
SPAT
Therapeutic discussion
2.4
12.0
110
505
N05CD07
ATC
temazepam; oral
4.9
12.0
39
83
N05AB03
ATC
perphenazine; systemic, rectal
5.5
12.0
35
66
IER01
NOMESCO Finland
Psychoeducation, group
10.2
12.0
23
23
ICC01
NOMESCO Finland
Psychiatric treatment plan, transfer to psychiatric outpatient clinic
9.5
12.0
24
26
T74.1
ICD-10 Finland
Physical abuse
5.0
12.0
38
79
N05BA12
ATC
alprazolam; oral
3.7
11.9
53
153
R53
ICD-10 Finland
Malaise and fatigue
2.3
11.6
118
567
N06AB05
ATC
paroxetine; oral
4.1
11.6
45
115
N06AX22
ATC
agomelatine; oral
5.8
11.5
32
57
Z06
ICPC
Unemployment problem
10.2
11.5
22
22
F95.2
ICD-10 Finland
Combined vocal and multiple motor tic disorder [de la Tourette]
121.0
11.4
12
*
N04AA02
ATC
biperiden; systemic
9.1
11.3
23
26
F31.6
ICD-10 Finland
Bipolar affective disorder, current episode mixed
9.8
11.2
22
23
K04.5
ICD-10 Finland
Chronic apical periodontitis
2.3
11.2
113
541
F51.9
ICD-10 Finland
Nonorganic sleep disorder, unspecified
6.9
11.2
27
40
N01
ICPC
Headache
2.1
11.1
145
782
F70.1
ICD-10 Finland
Mild mental retardation, Significant impairment of behaviour requiring attention or treatment
20.3
11.1
16
8
Z72.2
ICD-10 Finland
Drug use
11.3
11.0
20
18
N05BE01
ATC
buspirone; oral
6.1
10.9
29
49
P76
ICPC
Depressive disorder
3.0
10.9
66
237
F15.2
ICD-10 Finland
Mental and behavioural disorders due to use of other stimulants, including caffeine, dependence syndrome
12.1
10.8
19
16
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.8
10.7
296
2074
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
1.8
10.7
311
2217
C07AB07
ATC
bisoprolol; oral
2.2
10.7
121
614
RT420
NOMESCO Finland
NA
21.7
10.7
15
7
F43.22
ICD-10 Finland
Adaptation disorder with mixed anxiety and depression
3.6
10.6
47
135
Z01.8
ICD-10 Finland
Other specified special examinations
2.1
10.6
126
650
F31.30
ICD-10 Finland
Bipolar disorder Depressive episode without somatic syndrome
6.1
10.6
28
47
ZXY60
NOMESCO Finland
2-person team, nurses
8.1
10.6
23
29
IEP02
NOMESCO Finland
Child-centred family therapy
7.1
10.6
25
36
ZXE17
NOMESCO Finland
Procedure duration 150 to 179 minutes
5.7
10.4
29
52
RT390
NOMESCO Finland
NA
+∞
10.4
10
*
N06BA07
ATC
modafinil; oral
32.8
10.3
13
*
R1220
NOMESCO Finland
Psychological examination of need and possibilities to rehabilitation
4.9
10.3
33
70
M54.5
ICD-10 Finland
Low back pain
1.9
10.3
172
1016
F60.8
ICD-10 Finland
Other specific personality disorders
9.7
10.3
20
21
EBA05
NOMESCO Finland
Complicated extraction of tooth
2.2
10.2
109
538
S29
ICPC
Skin symptom/complaint other
2.2
10.1
106
517
ZYB04
NOMESCO Finland
Outreach service in patient’s home or everyday environment
11.4
10.0
18
16
P74
ICPC
Anxiety disorder/anxiety state
3.2
10.0
51
165
F32.3
ICD-10 Finland
Severe depressive episode with psychotic symptoms
5.1
9.9
30
60
SGA01
NOMESCO Finland
Tooth opening as first aid
2.1
9.9
121
632
EBA15
NOMESCO Finland
Extraction of large number of teeth
4.5
9.9
34
78
N06AX21
ATC
duloxetine; oral
3.0
9.8
58
207
IBB01
NOMESCO Finland
Psychiatric functioning capacity evaluation
20.2
9.8
14
7
A04
ICPC
Weakness/tiredness general
2.3
9.8
98
470
N03AF01
ATC
carbamazepine; oral, rectal
5.2
9.7
29
57
E66.01
ICD-10 Finland
Obesity due to excess calories
2.8
9.7
64
244
G40.9
ICD-10 Finland
Epilepsy, unspecified
4.2
9.7
36
89
F10.20
ICD-10 Finland
Alcohol dependence currently independent
6.2
9.7
25
41
Z61.8
ICD-10 Finland
Other negative life events in childhood
13.5
9.7
16
12
34408
ICD-8 Finland
Other cerebral paralysis, Alia definita
55.4
9.6
11
*
IEY01
NOMESCO Finland
Psychoeducation, individual
7.9
9.6
21
27
W0A12
NOMESCO Finland
Planned therapy visit for psychiatric disease
11.5
9.6
17
15
B18.2
ICD-10 Finland
Chronic viral hepatitis C
6.1
9.5
25
42
ZXY80
NOMESCO Finland
Doctor in multidisciplinary team
9.2
9.5
19
21
ZXD10
NOMESCO Finland
Scheduled procedure
1.8
9.5
206
1329
G44.2
ICD-10 Finland
Tension-type headache
2.5
9.5
78
337
D01
ICPC
Abdominal pain/cramps general
2.2
9.4
106
534
S10
ICPC
Boil/carbuncle
3.6
9.4
41
117
30920
ICD-8 Finland
Mental disorders not specified as psychotic associated with physical conditions, Brain trauma
100.6
9.4
10
*
F91.0
ICD-10 Finland
Conduct disorder confined to the family context
+∞
9.4
9
*
F43.1
ICD-10 Finland
Post-traumatic stress disorder
4.4
9.3
33
78
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
3.2
9.3
49
162
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.1
9.3
107
544
SPAT1307
SPAT
Psychosocial counselling and guidance
2.3
9.3
90
424
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.8
9.3
181
1123
X78
ICD-10 Finland
Intentional self-harm by sharp object
10.8
9.3
17
16
F10.00
ICD-10 Finland
Alcohol-related acute intoxication uncomplicated
6.5
9.3
23
36
F20.00
ICD-10 Finland
Paranoid schizophrenia continuous
4.6
9.2
31
70
ZY000
NOMESCO Finland
Hospital inpatient
5.4
9.1
26
49
F80.2
ICD-10 Finland
Receptive language disorder
5.7
9.1
25
45
IER02
NOMESCO Finland
Dedicated profession-specific psychiatric intervention, group
7.1
9.0
21
30
W0A10
NOMESCO Finland
Mapping of psychosocial situation
15.7
9.0
14
9
ICC03
NOMESCO Finland
Psychiatric treatment plan, transfer to psychiatric ward
15.7
9.0
14
9
IAB01
NOMESCO Finland
Psychiatric pharmacotherapy consultation
10.1
9.0
17
17
K08.3
ICD-10 Finland
Retained dental root
3.7
9.0
38
106
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
2.0
8.9
118
634
ZXE00
NOMESCO Finland
One hour or less
1.7
8.9
237
1616
J45.9
ICD-10 Finland
Asthma, unspecified
2.1
8.9
104
530
3153X
ICD-9 Finland
Specific delays in development, Developmental speech or language disorder[PUHEEN KEHITYKSEN ERITYISVAIKEUS]
24.2
8.9
12
5
J01DB01
ATC
cefalexin; oral
1.7
8.9
487
4074
F33.00
ICD-10 Finland
Recurrent depression, mild episode without somatic syndrome
5.0
8.8
27
55
N06AX26
ATC
vortioxetine; oral
2.8
8.8
55
203
F32.00
ICD-10 Finland
Mild depressive episode without somatic syndrome
3.6
8.8
38
108
Z76.8
ICD-10 Finland
Persons encountering health services in other specified circumstances
3.6
8.8
38
108
N03AE01
ATC
clonazepam; systemic
3.9
8.8
35
93
X44
ICD-10 Finland
Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances
6.0
8.8
23
39
TPH04
NOMESCO Finland
Cathetrisation of vein
2.1
8.8
109
571
SPAT1389
SPAT
Visit based on need for special support
2.5
8.7
69
294
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
3.0
8.7
49
168
R56.8
ICD-10 Finland
Other and unspecified convulsions
2.6
8.6
64
260
ZXY02
NOMESCO Finland
Neuropsychologist
16.4
8.5
13
8
F42.1
ICD-10 Finland
Predominantly compulsive acts [obsessional rituals]
9.1
8.5
17
19
ZXE01
NOMESCO Finland
Procedure duration 0 to 9 minutes
5.2
8.5
25
49
A46
ICD-10 Finland
Erysipelas
3.1
8.5
46
156
F10.25
ICD-10 Finland
Alcohol dependence continuous use
7.4
8.4
19
26
R4170
NOMESCO Finland
Therapy forms involving educational rehabilitation
90.4
8.4
9
*
N02BE01
ATC
paracetamol; systemic, rectal
1.6
8.4
403
3220
WX290
NOMESCO Finland
Other blockade of nerve
1.6
8.4
330
2498
ZXY81
NOMESCO Finland
Psychologist in multidisciplinary team
12.9
8.4
14
11
L12
ICPC
Hand/finger symptom/complaint
2.0
8.4
114
621
F98.2
ICD-10 Finland
Feeding disorder of infancy and childhood
+∞
8.3
8
*
F91.8
ICD-10 Finland
Other conduct disorders
+∞
8.3
8
*
R1270
NOMESCO Finland
Evaluation of the need for educational rehabilitation
+∞
8.3
8
*
T90.5
ICD-10 Finland
Sequelae of intracranial injury
8.6
8.3
17
20
R07.4
ICD-10 Finland
Chest pain, unspecified
2.1
8.3
94
474
F19.20
ICD-10 Finland
Addiction relationship caused by several drugs in combination and by other psychoactive substances currently independent
10.8
8.3
15
14
Z3229
NOMESCO Finland
Other healthcare associate professional
2.4
8.2
68
295
N05BA06
ATC
lorazepam; systemic, sublingual
4.2
8.2
30
74
TKC20
NOMESCO Finland
Catheterisation of bladder
4.2
8.2
30
74
A03
ICPC
Fever
1.7
8.2
181
1165
M79.6
ICD-10 Finland
Pain in limb
1.8
8.2
162
1007
P03
ICPC
Feeling depressed
2.1
8.2
101
526
Z71.8
ICD-10 Finland
Other specified counselling
1.8
8.2
157
964
N06AA06
ATC
trimipramine; systemic
7.6
8.1
18
24
Y07
ICD-10 Finland
Other maltreatment
8.2
8.1
17
21
SFA20
NOMESCO Finland
Filling on two surfaces of tooth
1.6
8.1
352
2727
3094A
ICD-9 Finland
Adjustment reaction, With mixed disturbance of emotions and conduct
33.5
8.1
10
*
F12.1
ICD-10 Finland
Mental and behavioural disorders due to use of cannabinoids, harmful use
6.9
8.1
19
28
F70.0
ICD-10 Finland
Mild mental retardation, With the statement of no, or minimal, impairment of behaviour
6.9
8.1
19
28
F31.7
ICD-10 Finland
Bipolar affective disorder, currently in remission
5.1
8.0
24
48
F41.1
ICD-10 Finland
Generalized anxiety disorder
2.7
8.0
52
199
F10.21
ICD-10 Finland
Alcohol dependence currently abstinent, but staying in restrictive environment
7.8
7.9
17
22
IEY08
NOMESCO Finland
Psychiatric coaching, domestic and community skills
13.1
7.9
13
10
F32
ICD-10 Finland
Depressive episode
2.9
7.8
47
171
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
2.0
7.8
110
607
R05
ICD-10 Finland
Cough
1.9
7.8
113
628
Z76.9
ICD-10 Finland
Person encountering health services in unspecified circumstances
2.6
7.7
57
234
F80.1
ICD-10 Finland
Expressive language disorder
4.3
7.7
27
64
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
1.7
7.7
222
1536
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.7
7.7
209
1423
F80.8
ICD-10 Finland
Other developmental disorders of speech and language
7.5
7.7
17
23
RS310
NOMESCO Finland
NA
18.5
7.6
11
6
ZXY01
NOMESCO Finland
Chief Physician, Head of Department or Deputy Chief Physician
6.8
7.6
18
27
L03
ICPC
Low back symptom/complaint
1.9
7.6
130
767
F32.1
ICD-10 Finland
Moderate depressive episode
2.6
7.6
52
205
N06AX05
ATC
trazodone; oral
5.2
7.5
22
43
K85
ICPC
Elevated blood pressure
3.5
7.5
34
101
E66.8
ICD-10 Finland
Other obesity
3.5
7.5
34
101
F10.09
ICD-10 Finland
Alcohol intoxication UNS
4.4
7.5
26
61
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.0
7.5
93
487
N05CF02
ATC
zolpidem; oral
2.2
7.5
73
344
P23
ICPC
Adolescent behaviour sympt/compl
7.2
7.5
17
24
RS220
NOMESCO Finland
NA
4.3
7.4
26
62
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
3.2
7.4
37
119
RT260
NOMESCO Finland
NA
80.3
7.4
8
*
N06AB08
ATC
fluvoxamine; oral
7.7
7.4
16
21
G47.9
ICD-10 Finland
Sleep disorder, unspecified
5.6
7.4
20
36
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.0
7.4
103
566
R21
ICPC
Throat symptom/complaint
1.7
7.3
211
1454
R41.0
ICD-10 Finland
Disorientation, unspecified
8.4
7.3
15
18
F15.1
ICD-10 Finland
Mental and behavioural disorders due to use of other stimulants, including caffeine, harmful use
8.4
7.3
15
18
F06.9
ICD-10 Finland
Unspecified mental disorder due to brain damage and dysfunction and to physical disease
+∞
7.3
7
*
30088
ICD-8 Finland
Neuroses, Other
+∞
7.3
7
*
F93.80
ICD-10 Finland
Generalized anxiety in the bardom age
+∞
7.3
7
*
F33.11
ICD-10 Finland
Recurrent depression, moderate episode of somatic syndrome
5.0
7.3
22
45
F11.22
ICD-10 Finland
Addiction-induced dependence is currently independent but uses substitute intermittent medication
9.4
7.3
14
15
F33.8
ICD-10 Finland
Other recurrent depressive disorders
9.4
7.3
14
15
WX002
NOMESCO Finland
Sedation and analgesia
2.2
7.3
74
356
K04.08
ICD-10 Finland
Other specified pulpit
2.5
7.2
56
235
Z72.0
ICD-10 Finland
Tobacco use
6.3
7.2
18
29
R03AC02
ATC
salbutamol; inhalant
1.6
7.2
325
2511
SFA30
NOMESCO Finland
Filling on tree or more surfaces of tooth
1.7
7.2
176
1159
R42
ICD-10 Finland
Dizziness and giddiness
2.2
7.2
74
360
WX110
SPAT
NA
2.8
7.1
45
167
K10.3
ICD-10 Finland
Alveolitis of jaws
3.2
7.1
36
117
AA1AD
NOMESCO Finland
CT of head and brain
2.1
7.1
76
375
ZXY49
NOMESCO Finland
Other health care provider
8.0
7.1
15
19
P22
ICPC
Child behaviour symptom/complaint
3.2
7.1
35
112
U07
ICPC
Urine symptom/complaint other
4.1
7.1
26
65
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
3.8
7.1
28
75
Z72.8
ICD-10 Finland
Other problems related to lifestyle
12.1
7.1
12
10
IBC98
NOMESCO Finland
Other child protection assessment
12.1
7.1
12
10
IBZ02
NOMESCO Finland
Somatic assessment of psychiatric patient
12.1
7.1
12
10
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
2.0
7.0
95
514
Z00.0
ICD-10 Finland
General medical examination
1.8
7.0
121
714
ZXY03
NOMESCO Finland
Occupational therapist
10.1
7.0
13
13
S20
ICPC
Corn/callosity
10.1
7.0
13
13
F98.00
ICD-10 Finland
Nonorganic enuresis nocturna
10.1
7.0
13
13
A10BA02
ATC
metformin; oral
2.4
7.0
60
265
I10
ICD-10 Finland
Essential (primary) hypertension
2.0
7.0
95
517
LC2AE
NOMESCO Finland
Ultrasound examination of uterus and parametria
2.6
7.0
51
207
SPAT1220
SPAT
Assessment of need for rehabilitation and/or rehabilitation plan
2.7
6.9
45
172
N06AX03
ATC
mianserin; oral
5.2
6.9
20
39
L01
ICPC
Neck symptom/complaint
2.1
6.9
76
377
Z01.4
ICD-10 Finland
Gynaecological examination (general)(routine)
2.1
6.9
78
391
S18
ICPC
Laceration/cut
1.6
6.9
190
1292
S00.0
ICD-10 Finland
Superficial injury of scalp
5.9
6.9
18
31
Z63.7
ICD-10 Finland
Other stressful life events affecting family and household
3.0
6.9
39
135
F19.29
ICD-10 Finland
Addiction caused by several drugs in combination and by other psychoactive substances UNS
7.6
6.9
15
20
N03AX12
ATC
gabapentin; oral
2.4
6.9
59
260
RS312
NOMESCO Finland
NA
13.8
6.9
11
8
A06AD11
ATC
lactulose; oral
2.7
6.8
45
174
ZXE20
NOMESCO Finland
More than three and less than five hours
2.2
6.8
73
357
SFC01
NOMESCO Finland
Adjuvant procedure of filling therapy
1.8
6.8
129
787
R4110
NOMESCO Finland
Physiotherapy
1.8
6.7
136
845
XA820
NOMESCO Finland
NA
16.8
6.7
10
6
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
2.7
6.7
43
163
R62.0
ICD-10 Finland
Delayed milestone
3.3
6.7
31
95
EBA30
NOMESCO Finland
Excision of root of tooth
3.8
6.7
26
69
D10
ICPC
Vomiting
2.1
6.7
79
407
T83
ICPC
Overweight
5.0
6.7
20
41
ZXE21
NOMESCO Finland
Procedure duration at least 3 but less than 4 hours
6.5
6.6
16
25
Z07
ICPC
Education problem
4.1
6.6
24
60
WZB00
NOMESCO Finland
Telephone receipt or other advice
1.6
6.5
179
1217
F10.26
ICD-10 Finland
Alcohol dependence periodic alcoholism
5.7
6.4
17
30
N02AX02
ATC
tramadol; systemic, rectal
1.7
6.4
139
881
F84.0
ICD-10 Finland
Childhood autism
14.4
6.4
10
7
285
Kela drug reimbursment
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)
4.9
6.3
19
39
L14
ICPC
Leg/thigh symptom/complaint
2.6
6.3
44
174
SPAT1317
SPAT
Planned health check-up monitoring, health check-up performed based on individual need
1.6
6.3
179
1224
K59.09
ICD-10 Finland
Constipation, unspecified
3.1
6.3
33
111
F11.29
ICD-10 Finland
Addiction caused by opiates UNS
11.1
6.3
11
10
R4120
NOMESCO Finland
Occupational therapy
2.6
6.3
42
165
Z63.8
ICD-10 Finland
Other specified problems related to primary support group
18.1
6.2
9
5
L28
ICPC
Limited function/disability (L)
2.5
6.2
47
195
X59
ICD-10 Finland
Exposure to unspecified factor
1.8
6.2
119
723
F95.1
ICD-10 Finland
Chronic motor or vocal tic disorder
+∞
6.2
6
*
F94.1
ICD-10 Finland
Reactive attachment disorder of childhood
+∞
6.2
6
*
SFA40
NOMESCO Finland
Replacement of krone of tooth
2.1
6.2
69
344
F80.9
ICD-10 Finland
Developmental disorder of speech and language, unspecified
4.4
6.2
21
49
Z61.2
ICD-10 Finland
Altered pattern of family relationships in childhood
26.7
6.2
8
*
F95.9
ICD-10 Finland
Tic disorder, unspecified
26.7
6.2
8
*
F42.9
ICD-10 Finland
Obsessive-compulsive disorder, unspecified
7.1
6.2
14
20
L02.3
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of buttock
4.0
6.2
23
59
SPAT1243
SPAT
Psychiatric/psychological examination
2.6
6.2
41
160
P16
ICPC
Acute alcohol abuse
5.1
6.2
18
36
F22.0
ICD-10 Finland
Delusional disorder
6.3
6.1
15
24
F10.24
ICD-10 Finland
Alcohol depence active use
5.8
6.1
16
28
F41.8
ICD-10 Finland
Other specified anxiety disorders
3.1
6.1
31
102
R06.5
ICD-10 Finland
Mouth breathing
2.3
6.1
55
251
P17
ICPC
Tobacco abuse
7.7
6.1
13
17
L08
ICPC
Shoulder symptom/complaint
2.0
6.1
75
393
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
3.3
6.1
28
86
F20.30
ICD-10 Finland
Undifferentiated schizophrenia continuous
3.9
6.1
23
60
F05.9
ICD-10 Finland
Delirium, unspecified
12.6
6.1
10
8
Z03
ICPC
Housing/neighbourhood problem
12.6
6.1
10
8
WZA90
NOMESCO Finland
Other doctors statement
1.6
6.1
179
1234
F33.1
ICD-10 Finland
Recurrent depressive disorder, current episode moderate
3.4
6.0
27
81
F19.25
ICD-10 Finland
Addiction caused by several drugs in combination and by other psychoactive substances continuously used
10.1
6.0
11
11
F60.6
ICD-10 Finland
Anxious [avoidant] personality disorder
10.1
6.0
11
11
F61
ICD-10 Finland
Mixed and other personality disorders
10.1
6.0
11
11
ZXY57
NOMESCO Finland
2-person team, nurse-social worker
10.1
6.0
11
11
F60.2
ICD-10 Finland
Dissocial personality disorder
10.1
6.0
11
11
R44.0
ICD-10 Finland
Auditory hallucinations
10.1
6.0
11
11
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3028707) Methadone [Presence] in Urine by Screen method
169
267
7.87
106.00
5.7
3.3
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
175
459
4.66
61.88
8.5
3.0
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
187
544
4.24
57.42
5.4
2.3
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
258
941
3.66
57.13
2.2
1.8
%
1.5
1.4
1.38
236
878
(3016879) Cocaine [Presence] in Urine
200
672
3.69
49.31
5.1
2.1
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
206
724
3.54
47.20
5.2
2.1
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
205
721
3.53
46.89
5.3
2.1
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
206
727
3.52
46.86
5.3
2.1
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
196
720
3.33
41.28
5.4
2.1
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
63
101
6.67
37.79
2.0
2.0
—
—
—
0
0
(4198724)
52
73
7.53
35.18
4.1
1.9
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
255
1185
2.75
34.41
1.7
1.6
pmol/l
96.0
99.6
0.69
142
650
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
322
1681
2.62
34.33
3.5
3.7
u/l
40.7
33.6
0.42
303
1610
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
370
2089
2.54
33.12
7.0
8.5
mmol/l
1.2
1.2
0.02
327
1858
(3009508) Creatinine [Moles/volume] in Urine
256
1240
2.62
31.28
5.7
4.3
mmol/l
8.2
9.1
1.27
227
1133
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
343
1917
2.47
30.74
6.7
8.6
mmol/l
1.2
1.2
0.20
323
1814
(3044889) 12 lead EKG panel
420
2610
2.41
29.17
3.0
2.4
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
558
3962
2.72
28.73
4.5
3.6
pmol/l
14.4
14.5
0.35
536
3663
(3018418) pH of Serum or Plasma
219
1038
2.56
27.44
4.0
4.4
ph
7.4
7.4
1.34
36
191
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
492
3340
2.43
27.09
5.8
6.5
u/l
85.4
90.4
1.20
470
3159
(3009466) Valproate [Moles/volume] in Serum or Plasma
55
119
4.87
23.88
5.1
5.6
umol/l
381.6
397.6
0.29
49
111
(3019550) Sodium [Moles/volume] in Serum or Plasma
639
5039
3.16
23.77
13.4
9.9
mmol/l
139.4
139.5
0.53
627
4899
(3023103) Potassium [Moles/volume] in Serum or Plasma
640
5054
3.17
23.69
13.3
9.9
mmol/l
3.9
3.9
2.20
624
4893
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
605
4654
2.74
23.27
5.3
4.0
mu/l
1.9
2.1
0.41
579
4414
(3021960) Folate [Moles/volume] in Serum or Plasma
149
639
2.65
22.47
1.5
1.3
nmol/l
17.7
19.2
0.86
135
578
(40758558) Short blood count panel - Blood
267
1521
2.17
20.91
7.1
8.1
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
188
941
2.32
20.08
2.3
2.2
u/l
193.5
381.8
1.44
178
906
(3013826) Glucose [Moles/volume] in Serum or Plasma
393
2620
2.06
19.97
4.3
5.4
mmol/l
6.5
6.4
0.23
370
2402
(3015377) Calcium [Moles/volume] in Serum or Plasma
222
1200
2.20
19.64
2.4
3.1
mmol/l
2.4
2.4
0.19
199
1090
(44816559) Phosphatidylethanol [Mass/volume] in Blood
59
164
3.79
18.48
1.6
1.3
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
323
2050
2.01
18.34
5.7
8.0
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
323
2058
2.00
18.07
4.8
6.3
umol/l
10.2
12.9
2.52
301
1931
(3019150) Specific gravity of Urine by Refractometry
194
1023
2.20
18.05
5.8
3.0
kg/l
1.0
1.0
0.15
16
161
(3019309) Folate [Moles/volume] in Red Blood Cells
97
372
2.83
17.97
1.7
1.6
nmol/l
1139.8
1118.1
0.08
80
296
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
535
4155
2.05
15.95
3.8
2.7
mmol/l
5.8
5.6
2.34
501
3870
(3021589) Normoblasts [#/volume] in Blood
383
2670
1.89
15.66
7.7
9.2
e9/l
0.0
0.0
1.25
289
2102
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
209
1215
1.99
14.57
2.6
2.8
u/l
53.7
58.1
1.07
191
1143
(3024561) Albumin [Mass/volume] in Serum or Plasma
261
1650
1.89
14.09
4.9
6.6
g/l
38.4
38.2
0.31
237
1558
(3030467) Casts [#/volume] in Urine by Automated count
216
1284
1.95
14.04
3.8
3.4
e6/l
0.2
0.2
0.26
163
966
(3013650) Neutrophils [#/volume] in Blood by Automated count
440
3277
1.84
13.89
11.6
10.1
e9/l
4.1
3.7
2.61
371
2812
(3018095) Leukocytes [#/volume] in Urine
264
1685
1.87
13.76
4.5
4.1
e6/l
112.0
89.4
0.09
184
1146
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
248
1563
1.87
13.38
3.9
3.7
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
159
871
2.04
12.92
4.0
4.2
—
—
—
0
0
(3015736) pH of Urine
275
1808
1.82
12.83
5.0
2.9
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
24
43
5.68
12.80
1.7
1.9
—
—
—
0
0
(3042517) Benzodiazepines panel - Urine
14
13
10.86
12.75
1.4
3.4
—
—
—
0
0
(3014111) Lactate [Moles/volume] in Serum or Plasma
92
407
2.42
12.65
5.0
9.1
mmol/l
1.3
1.4
1.13
85
381
(3002582) Erythrocytes [#/volume] in Urine
227
1412
1.86
12.64
3.8
3.6
e6/l
145.0
41.6
0.56
168
1081
(3042936) Bacteria identified in Isolate by Culture
113
550
2.23
12.45
1.9
2.1
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
291
1972
1.77
12.09
3.2
2.9
nmol/l
66.0
69.4
1.43
278
1881
(36304419) Bacteria [Presence] in Urine
212
1314
1.85
11.81
3.8
3.3
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
397
2955
1.73
11.70
6.6
7.8
e9/l
0.0
0.0
0.24
326
2558
(3001604) Monocytes [#/volume] in Blood
396
2954
1.72
11.50
6.7
7.8
e9/l
0.6
0.5
0.85
326
2556
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
480
3781
1.76
11.42
4.7
3.6
mmol/mol
37.6
37.3
0.28
453
3622
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
188
1135
1.87
11.32
2.7
2.9
mg/l
2.6
2.6
0.12
167
995
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
139
763
2.00
11.10
3.4
3.1
e6/l
3.3
2.4
0.29
76
412
(3022096) Basophils/100 leukocytes in Blood
371
2742
1.70
10.94
6.6
8.0
%
0.6
0.6
0.21
356
2614
(3019198) Lymphocytes [#/volume] in Blood
406
3092
1.68
10.54
6.7
7.7
e9/l
2.2
2.1
1.67
345
2728
(3026782) Osmolality of Urine
157
913
1.90
10.54
2.7
2.8
mosm/kgh2o
612.2
596.7
0.24
134
798
(3021387) Prolactin [Units/volume] in Serum or Plasma
80
361
2.34
10.49
1.9
1.5
mu/l
430.4
275.0
1.33
73
327
(3033658) Prothrombin time (PT) actual/Normal
203
1284
1.79
10.38
4.9
5.4
%
89.9
90.3
0.08
196
1251
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
94
456
2.20
10.38
2.6
2.6
u/l
26.5
141.2
0.57
81
393
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
137
768
1.95
10.25
3.4
3.0
e6/l
0.6
0.9
0.59
72
412
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
96
473
2.17
10.20
1.7
2.4
mmol/l
2.4
2.4
0.12
81
408
(3019069) Monocytes/100 leukocytes in Blood
379
2853
1.66
10.14
6.7
8.0
%
8.1
8.3
1.12
365
2727
(3013115) Eosinophils [#/volume] in Blood
399
3045
1.66
10.11
7.6
8.3
e9/l
0.2
0.2
0.04
335
2679
(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method
14
18
7.84
10.05
1.0
1.0
—
—
—
0
0
(3020191) Ethanol [Moles/volume] in Serum or Plasma
25
58
4.39
9.98
1.3
1.3
promille
1.4
1.4
0.03
19
45
(3028772) Osteocalcin [Mass/volume] in Serum or Plasma
21
42
5.07
9.96
3.0
2.9
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
647
5683
2.19
9.96
10.0
8.1
u/l
31.0
29.8
0.48
634
5530
(3006504) Eosinophils/100 leukocytes in Blood
375
2827
1.65
9.88
6.6
7.8
%
2.9
3.0
0.56
358
2690
(3002385) Erythrocyte distribution width [Ratio]
603
5190
1.90
9.49
18.4
12.7
%
13.2
13.2
0.61
593
5090
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
467
3750
1.66
9.36
4.6
3.3
u/l
41.3
35.7
1.25
448
3628
(3020485) Acetaminophen [Moles/volume] in Serum or Plasma
15
23
6.58
9.27
2.2
6.6
umol/l
269.6
275.4
—
8
11
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
513
4250
1.67
8.81
10.9
7.6
ml/min/173m2
104.9
102.1
2.14
402
3216
(3018010) Neutrophils/100 leukocytes in Blood
383
2956
1.60
8.78
6.4
7.4
%
53.9
53.2
0.49
369
2831
(3002030) Lymphocytes/100 leukocytes in Blood
387
3002
1.59
8.62
6.8
7.6
%
31.7
32.3
0.54
370
2873
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
104
564
1.97
8.50
3.3
2.7
%
24.4
24.5
0.05
97
511
(3011397) Hemoglobin [Presence] in Urine by Test strip
165
1037
1.75
8.42
3.4
2.9
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
154
949
1.77
8.42
2.8
3.0
e6/l
8.8
5.7
1.14
133
835
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
11
13
8.50
8.39
1.1
1.1
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
55
233
2.45
8.29
1.9
1.3
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
166
1050
1.73
8.27
1.7
1.7
mmol/l
1.8
1.4
2.43
155
948
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
118
675
1.87
8.21
3.2
2.9
ng/l
878.5
1173.4
0.19
70
366
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
100
549
1.93
7.87
1.6
1.6
pmol/l
417.5
29880904.1
0.80
87
502
(3014576) Chloride [Moles/volume] in Serum or Plasma
85
442
2.03
7.80
5.3
8.5
mmol/l
104.4
104.8
0.29
85
435
(3013512) EKG study
127
758
1.80
7.69
2.7
2.4
—
—
—
0
0
(3000991) Gas panel - Venous blood
114
660
1.84
7.62
7.7
9.5
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
532
4538
1.61
7.22
3.9
3.1
mmol/l
2.8
2.9
0.54
501
4314
(3013707) Erythrocyte sedimentation rate by Westergren method
434
3556
1.52
6.88
3.8
3.9
mm/h
7.5
7.3
0.24
407
3330
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
48
209
2.37
6.84
1.6
1.4
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
121
737
1.75
6.80
1.3
1.2
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
182
1235
1.61
6.80
5.9
4.9
inr
1.0
1.1
2.21
60
387
(21494755) Public health laboratory ask at order entry panel
44
912
0.44
6.60
1.2
1.3
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
528
4546
1.55
6.39
3.7
3.1
mmol/l
4.6
4.6
0.66
496
4357
(3037467) Urinalysis macro (dipstick) panel - Urine
401
3266
1.48
6.30
4.5
3.8
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
28
97
2.93
6.27
2.6
8.8
—
—
—
0
0
(3021447) Carbon dioxide [Partial pressure] in Venous blood
116
714
1.73
6.26
5.5
7.3
kpa
5.9
5.8
0.19
108
697
(3002032) Base excess in Venous blood by calculation
115
710
1.72
6.14
5.6
7.3
mmol/l
0.8
1.4
0.84
93
571
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
523
4511
1.53
6.11
3.7
3.0
mmol/l
1.3
1.4
4.59
493
4306
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
160
1079
1.60
6.07
2.7
2.4
ng/l
10.7
37.8
0.80
71
428
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
74
403
1.91
5.96
1.6
1.7
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
99
593
1.76
5.87
5.5
7.2
mmol/l
23.6
23.8
0.18
92
581
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
74
407
1.89
5.79
1.6
1.8
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
59
301
2.03
5.73
5.8
11.4
mmol/l
0.3
0.5
0.11
52
247
(3024354) Oxygen [Partial pressure] in Venous blood
106
653
1.71
5.69
4.9
7.2
kpa
5.1
5.2
0.17
98
638
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
623
5630
1.68
5.62
13.0
9.8
mg/l
22.0
21.4
0.17
495
4015
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
42
189
2.28
5.59
1.8
1.6
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
141
945
1.59
5.45
3.9
2.2
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
86
514
1.75
5.14
3.1
4.2
ng/l
744.4
754.3
0.01
66
402
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
33
688
0.45
4.99
1.7
1.5
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
137
1899
0.65
4.93
2.6
2.1
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
228
1725
1.45
4.92
1.6
1.5
g/l
1.9
2.0
0.29
109
1012
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
57
310
1.89
4.64
3.4
2.4
—
—
—
0
0
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
39
185
2.15
4.61
6.9
12.6
mmol/l
24.0
24.2
0.26
39
178
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
75
446
1.74
4.57
3.3
3.8
g/l
0.2
0.2
0.30
67
424
(40761511) CBC panel - Blood by Automated count
638
5867
1.64
4.56
11.7
8.0
—
—
—
0
0
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
41
200
2.09
4.52
6.8
12.9
%
0.7
0.7
0.25
41
200
(3002173) Hemoglobin [Mass/volume] in Arterial blood
46
236
1.99
4.44
6.3
12.7
g/l
125.6
127.3
0.23
46
225
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
243
1891
1.41
4.41
1.6
1.6
u/ml
1.9
1.7
0.14
45
417
(3020682) Albumin/Creatinine [Ratio] in Urine
111
739
1.58
4.38
4.7
4.8
mg/mmol
10.1
12.1
0.19
79
555
(3012095) Magnesium [Moles/volume] in Serum or Plasma
103
674
1.60
4.37
5.4
7.2
mmol/l
0.8
0.8
1.04
97
649
(3001122) Ferritin [Mass/volume] in Serum or Plasma
311
2527
1.38
4.36
3.6
3.1
ug/l
83.9
84.9
0.03
295
2409
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
21
492
0.41
4.27
1.5
1.3
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
90
574
1.63
4.24
1.7
1.8
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
100
658
1.59
4.15
2.0
1.6
—
—
—
0
0
(40761535) Cells panel - Urine sediment
45
236
1.95
4.10
3.5
3.2
—
—
—
0
0
(1616796) Gas panel - Central venous blood
24
97
2.50
4.09
6.0
3.8
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
47
251
1.91
4.06
3.7
2.5
ml/min/173m2
85.8
85.3
0.02
16
98
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
92
601
1.59
3.94
5.8
6.8
mmol/l
1.3
1.0
0.55
60
440
(3017143) Hepatitis C virus Ab [Presence] in Serum
149
1081
1.46
3.91
2.2
1.7
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
105
709
1.55
3.89
4.3
3.9
mg/l
68.7
275.6
0.99
76
524
(3016502) Oxygen saturation in Arterial blood
49
270
1.86
3.86
6.4
12.4
%
94.7
96.8
0.96
49
258
(3009343) pH of Capillary blood
92
604
1.58
3.85
5.8
6.9
ph
7.4
7.4
—
9
30
(3012501) Base excess in Blood by calculation
22
88
2.52
3.84
6.1
5.5
mmol/l
2.0
2.7
0.50
16
47
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
54
308
1.80
3.82
2.0
1.4
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
92
606
1.58
3.80
5.8
6.8
kpa
5.2
5.1
0.91
86
574
(3052851) Hemolysis interference index of Serum or Plasma
31
146
2.15
3.77
3.2
2.9
—
—
—
0
0
(3017509) Phencyclidine [Presence] in Urine
7
8
8.74
3.75
2.0
1.4
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
39
202
1.96
3.70
1.6
1.3
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
35
177
2.01
3.55
2.0
1.8
ug/l
7.9
9.1
0.17
29
159
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
88
583
1.56
3.55
4.2
4.9
umol/l
9.0
6.3
0.44
67
488
(3001019) Free T4 and TSH panel - Serum or Plasma
15
373
0.39
3.53
1.3
1.5
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
280
2294
1.34
3.53
3.5
3.0
estimate
0.0
0.0
0.00
52
426
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
486
4315
1.35
3.53
3.5
2.8
mmol/l
1.5
1.2
4.34
451
4122
(40767503) Oxygen content in Capillary blood by calculation
19
74
2.59
3.51
2.1
2.7
%
18.5
17.8
0.47
12
39
(40768797) Stomach Pathology biopsy report
79
512
1.59
3.50
1.2
1.3
—
—
—
0
0
(3020891) Body temperature
25
112
2.25
3.44
4.9
6.3
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
694
6605
1.96
3.43
21.5
14.1
e9/l
266.9
259.1
2.54
675
6412
(3037522) Nuclear Ab [Titer] in Serum
109
766
1.48
3.35
1.5
1.4
titre
466.7
431.7
0.08
12
125
(3006576) Bicarbonate [Moles/volume] in Blood
8
14
5.71
3.32
3.9
4.9
mmol/l
23.8
24.9
—
8
14
(3009261) Glucose [Presence] in Urine by Test strip
280
2316
1.32
3.24
3.5
3.0
estimate
0.0
0.0
0.00
52
430
(3035941) MCH [Entitic mass]
694
6616
1.92
3.23
21.2
14.0
pg
29.6
29.7
0.31
688
6551
(3026361) Erythrocytes [#/volume] in Blood
694
6616
1.92
3.23
21.3
14.0
e12/l
4.7
4.7
0.08
675
6413
(3010813) Leukocytes [#/volume] in Blood
694
6620
1.90
3.16
21.4
14.1
e9/l
7.0
6.6
6.40
675
6418
(3000963) Hemoglobin [Mass/volume] in Blood
694
6621
1.90
3.14
21.5
14.2
g/l
139.0
139.4
0.30
688
6551
(3021601) Nitrite [Presence] in Urine by Test strip
276
2288
1.32
3.12
4.8
4.3
estimate
0.0
0.0
0.50
55
454
(3025130) Human papilloma virus identified in Specimen
18
73
2.48
3.09
1.4
1.7
—
—
—
0
0
(3024731) MCV [Entitic volume]
693
6614
1.86
3.05
21.3
14.0
fl
88.0
88.0
0.03
687
6548
(3019225) pH of Specimen
46
274
1.71
2.86
2.8
4.0
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
20
91
2.21
2.70
1.5
3.1
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
22
105
2.11
2.65
1.5
4.3
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
104
760
1.42
2.62
10.5
9.1
mmol/l
1.2
1.2
1.74
99
727
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
37
603
0.59
2.61
1.6
1.5
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
69
468
1.51
2.55
2.8
2.7
u/l
12832.4
4225.7
0.67
18
194
(3012984) Norclozapine [Mass/volume] in Serum or Plasma
6
11
5.44
2.53
6.8
10.0
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
18
82
2.20
2.44
6.7
9.6
u/ml
0.2
0.3
1.68
11
43
(3000330) Specific gravity of Urine by Test strip
25
130
1.94
2.42
1.8
2.3
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
17
76
2.25
2.40
1.9
1.8
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
70
483
1.48
2.39
1.2
1.3
iu/ml
100.2
154.8
0.45
19
179
(3007463) Buprenorphine [Presence] in Urine
6
12
4.98
2.38
1.0
4.1
—
—
—
0
0
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
15
64
2.35
2.35
1.2
1.5
mmol/l
13.6
12.5
—
6
12
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
27
146
1.86
2.34
1.8
2.2
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
60
403
1.52
2.33
1.5
2.0
u/l
6.6
6.4
0.06
36
295
(3029937) Albumin [Presence] in Urine by Test strip
145
1142
1.32
2.29
3.7
3.3
estimate
0.0
0.0
1.08
53
434
(3002256) Pathology report gross observation
66
455
1.48
2.27
1.2
1.2
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
22
396
0.54
2.23
2.1
1.8
—
—
—
0
0
(3028626) Oxygen [Partial pressure] in Capillary blood
70
491
1.46
2.21
6.4
7.3
kpa
9.5
9.8
0.79
65
468
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
42
263
1.62
2.21
1.2
1.8
mg/l
4.8
3.0
0.71
33
166
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
50
327
1.55
2.20
3.0
1.8
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
74
526
1.44
2.19
1.5
1.5
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
8
24
3.33
2.16
1.3
2.5
umol/l
23.6
18.8
—
8
24
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
11
42
2.62
2.15
1.6
1.7
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
195
1612
1.27
2.13
2.6
2.2
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
22
115
1.92
2.12
1.3
1.2
—
—
—
0
0
(3011648) Oxygen content in Venous blood
13
55
2.37
2.09
2.9
12.5
%
12.5
12.7
0.05
13
55
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
13
55
2.37
2.09
1.5
1.4
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
13
270
0.47
2.04
1.6
1.8
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
61
424
1.46
2.04
1.6
1.8
iu/l
16.6
14.3
0.25
37
314
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
15
69
2.18
2.01
8.3
5.9
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
240
2045
1.24
2.01
2.7
2.1
—
—
—
0
0
(3019060) Gas panel - Arterial blood
24
132
1.83
2.00
3.1
7.8
—
—
—
0
0
(3022621) pH of Urine by Test strip
36
223
1.63
2.00
2.0
2.2
—
—
—
0
0
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
12
50
2.40
1.99
5.3
6.4
mg/l
9.5
9.0
0.13
12
45
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
23
125
1.85
1.99
1.4
2.4
g/l
1.2
1.2
0.16
18
118
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
48
321
1.52
1.94
5.1
4.8
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
120
1478
0.77
1.93
1.5
1.6
—
—
—
0
0
(3003434) Protein [Mass/volume] in Pleural fluid
5
11
4.53
1.93
1.4
1.3
g/l
44.5
38.8
—
5
11
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
208
1752
1.25
1.92
2.9
2.3
—
—
—
0
0
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
28
164
1.72
1.91
1.4
3.2
e6/l
67.7
12.9
0.73
15
120
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
28
164
1.72
1.91
1.4
3.2
e6/l
24.7
1113.4
0.56
15
125
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
50
339
1.50
1.90
3.0
2.7
%
29.1
30.9
0.67
40
258
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
99
759
1.34
1.89
1.3
1.2
iu/ml
26.6
17.9
0.33
22
211
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
101
781
1.33
1.82
2.4
2.0
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
170
1408
1.26
1.81
2.2
2.6
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
22
122
1.81
1.81
1.1
1.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
22
122
1.81
1.81
1.1
1.3
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
26
152
1.72
1.80
1.5
3.3
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
11
230
0.47
1.79
1.4
1.5
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
44
295
1.51
1.77
1.3
1.2
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
27
161
1.69
1.75
8.1
15.4
—
—
—
0
0
(3013336) Amino acids [Identifier] in Serum or Plasma
6
18
3.32
1.73
1.0
2.7
—
—
—
0
0
(3020779) Urea [Moles/volume] in Serum or Plasma
71
525
1.38
1.72
12.5
11.0
mmol/l
6.3
5.8
0.42
71
515
(3045414) Leukocytes [Presence] in Urine
26
155
1.69
1.69
1.8
1.6
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
123
989
1.28
1.67
2.4
2.8
mg/l
1.6
1.1
0.40
83
676
(3015235) Bicarbonate [Moles/volume] in Capillary blood
20
111
1.81
1.65
3.5
10.8
mmol/l
23.8
23.4
0.22
20
100
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
13
62
2.10
1.62
1.5
1.5
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
81
618
1.34
1.62
2.1
2.2
ug/l
0.8
1.1
3.07
75
576
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
20
112
1.79
1.61
1.3
1.6
—
—
—
0
0
(3022313) Gas panel - Capillary blood
70
523
1.36
1.60
6.9
6.7
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
22
128
1.72
1.57
1.3
1.1
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
34
222
1.54
1.57
2.4
1.9
u/ml
90.3
99.6
—
6
34
(3006653) Thiamine [Moles/volume] in Blood
6
20
2.99
1.56
1.5
1.2
nmol/l
163.8
141.2
—
6
20
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
17
294
0.56
1.56
1.6
1.6
—
—
—
0
0
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
7
26
2.68
1.56
1.0
1.0
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
24
144
1.67
1.54
1.0
1.1
u/ml
7.0
2.4
—
8
60
(3023520) Reticulocytes [#/volume] in Blood
47
330
1.44
1.54
2.5
4.6
e9/l
71.8
68.1
0.16
27
218
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
0
41
0.00
1.53
0.0
1.4
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
41
281
1.47
1.52
1.1
1.4
—
—
—
0
0
(4268621)
13
64
2.03
1.51
2.0
2.4
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
33
216
1.54
1.51
1.5
1.8
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
66
494
1.36
1.50
4.4
6.4
%
1.5
1.5
0.20
61
462
(3021879) Hepatitis B virus core Ab [Presence] in Serum
87
681
1.30
1.47
1.9
1.5
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
13
65
2.00
1.46
1.2
1.2
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
15
81
1.85
1.37
1.0
1.1
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
14
74
1.89
1.36
2.4
8.4
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
38
263
1.46
1.36
1.4
1.7
—
—
—
0
0
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
11
53
2.07
1.36
1.4
1.2
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
12
60
2.00
1.35
1.2
1.3
—
—
—
0
0
(3008092) Baker's yeast IgG Ab [Units/volume] in Serum
6
23
2.60
1.35
1.0
1.3
—
25.3
—
0
6
(3008152) Bicarbonate [Moles/volume] in Arterial blood
20
119
1.68
1.35
5.1
11.8
mmol/l
24.5
24.2
0.13
20
107
(3041672) Baker's yeast Ab [Presence] in Serum
5
17
2.93
1.34
1.0
1.2
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
78
610
1.30
1.34
2.7
2.3
nmol/l
11.1
13.5
1.83
69
546
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
34
231
1.48
1.33
2.5
1.9
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
106
862
1.26
1.33
2.6
3.0
umol/l
3999.6
3604.5
0.04
91
802
(3005322) IgE [Units/volume] in Serum or Plasma
66
505
1.32
1.32
1.3
1.3
u/ml
175.7
404.1
1.49
61
467
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
89
712
1.27
1.29
1.3
1.2
u/ml
9.5
5.9
0.30
37
298
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
8
34
2.35
1.28
1.0
1.2
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
556
5729
0.83
1.24
4.2
3.8
—
—
—
0
0
(40768443) Skin Pathology biopsy report
22
138
1.60
1.23
1.0
1.1
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
6
25
2.39
1.23
1.8
1.2
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
21
131
1.61
1.20
2.1
1.6
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
19
116
1.64
1.18
1.1
1.4
ug/g
291.3
351.7
—
10
67
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
27
180
1.50
1.18
1.1
1.1
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
13
221
0.58
1.17
1.5
1.6
iu/ml
20.0
0.1
—
5
45
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
8
39
2.04
1.14
8.9
9.3
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
54
412
1.32
1.13
1.4
2.0
g/l
1.1
1.1
0.06
48
382
(3014765) Yersinia sp identified in Stool by Organism specific culture
27
182
1.49
1.13
1.1
1.1
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
7
31
2.25
1.10
2.0
1.5
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
11
58
1.89
1.10
1.0
1.1
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
27
184
1.47
1.08
1.1
1.2
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
131
1118
1.20
1.06
2.2
2.4
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
58
453
1.29
1.04
1.3
1.3
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
66
525
1.27
1.03
1.8
3.3
g/l
9.8
9.9
0.16
60
489
(3004775) Volume in Urine collected for unspecified duration
5
22
2.26
1.02
1.8
2.4
ml
956.8
614.6
—
5
14
(43055514) Macroprolactin [Presence] in Serum or Plasma
5
22
2.26
1.02
1.2
1.2
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
9
47
1.91
1.01
1.0
1.1
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
70
563
1.26
1.00
1.1
1.1
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
13
75
1.73
1.00
1.2
1.0
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
7
35
1.99
0.99
1.1
1.3
—
—
—
0
0
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
9
159
0.56
0.99
1.4
1.7
u/ml
43.0
33.0
—
9
151
(3050129) First trimester maternal screen panel - Serum or Plasma
29
395
0.72
0.98
1.6
1.4
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
64
512
1.26
0.96
1.6
1.9
—
—
—
0
0
(3034860) Kappa light chains.free [Mass/volume] in Serum
7
36
1.94
0.96
1.1
2.9
mg/l
69.6
28.7
—
7
30
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
7
36
1.94
0.96
1.1
2.9
mg/l
102.0
22.5
—
7
30
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
9
50
1.79
0.96
1.6
1.1
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
9
50
1.79
0.96
2.2
2.2
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
9
50
1.79
0.96
1.6
1.1
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
15
92
1.63
0.94
1.2
1.4
u/ml
1.2
5.3
—
5
40
(3003740) Influenza virus B Ag [Presence] in Specimen
13
207
0.62
0.94
1.1
1.1
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
17
108
1.57
0.94
2.6
1.5
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
9
51
1.76
0.93
1.6
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
9
51
1.76
0.93
1.6
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
9
51
1.76
0.93
1.6
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
9
51
1.76
0.93
1.6
1.1
—
—
—
0
0
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
20
133
1.50
0.92
1.6
1.5
nmol/l
0.2
0.4
1.00
15
113
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
24
333
0.70
0.91
1.4
1.5
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
111
950
1.19
0.88
2.6
2.1
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
43
331
1.31
0.88
1.2
1.2
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
15
94
1.59
0.88
1.4
1.6
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
46
358
1.29
0.87
4.8
4.7
%
0.4
0.6
0.27
13
100
(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay
8
43
1.85
0.87
1.0
1.1
%
77.9
78.5
—
8
43
(3028679) Herpes simplex virus Ab [Presence] in Serum
8
43
1.85
0.87
1.0
1.1
—
—
—
0
0
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
8
43
1.85
0.87
1.0
1.1
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
10
56
1.78
0.86
1.2
1.8
—
—
—
0
0
(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma
10
56
1.78
0.86
1.0
1.1
mg/l
297.6
291.5
—
10
48
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
6
31
1.93
0.83
1.2
1.5
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
6
31
1.93
0.83
1.7
1.0
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
6
31
1.93
0.83
1.5
1.2
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
22
153
1.44
0.83
1.5
1.8
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
124
1078
1.17
0.83
2.7
3.2
ug/g
88.1
121.9
0.70
101
869
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
44
344
1.28
0.82
10.2
14.5
mg/l
1.2
1.1
0.71
44
335
(3028433) Virus identified in Specimen by Culture
6
32
1.86
0.81
1.0
1.3
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
8
47
1.69
0.80
1.0
1.0
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
8
47
1.69
0.80
1.0
1.0
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
23
312
0.72
0.79
1.4
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
23
312
0.72
0.79
1.4
1.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
23
312
0.72
0.79
1.4
1.4
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
172
1538
1.14
0.79
2.1
1.7
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
57
463
1.24
0.78
1.7
2.2
%
25.9
23.6
—
7
97
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
0
26
0.00
0.78
0.0
2.9
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
6
33
1.81
0.78
7.8
3.4
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
14
208
0.66
0.78
1.1
1.1
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
23
311
0.72
0.78
1.4
1.4
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
5
99
0.50
0.78
1.2
3.5
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
9
53
1.69
0.75
1.8
2.5
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
5
24
2.07
0.74
1.0
1.0
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
5
24
2.07
0.74
1.0
1.0
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
5
24
2.07
0.74
1.0
1.0
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
8
131
0.60
0.74
1.1
1.2
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
10
59
1.69
0.74
1.0
1.1
—
—
—
0
0
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
5
25
1.99
0.72
3.8
5.0
ug/l
23.1
26.2
—
5
25
(3003327) Ova and parasites identified in Stool by Light microscopy
40
316
1.27
0.71
1.7
1.8
—
—
—
0
0
(4027681)
9
58
1.54
0.69
1.3
1.2
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
11
167
0.65
0.69
1.1
1.3
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
7
117
0.59
0.68
1.0
1.1
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
38
300
1.27
0.68
1.6
1.6
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
7
42
1.66
0.68
1.3
1.4
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
5
91
0.54
0.67
1.2
1.4
—
—
—
0
0
(4306422)
13
85
1.52
0.67
1.1
1.2
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
13
85
1.52
0.67
1.5
1.8
ug/l
5.9
1.3
0.40
13
77
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
7
44
1.58
0.64
1.1
1.2
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
37
294
1.26
0.64
1.6
1.6
u/ml
237.1
186.7
0.43
19
153
(3002179) Metamyelocytes/100 leukocytes in Blood
42
339
1.24
0.63
4.1
4.2
%
0.0
0.4
5.90
12
74
(3004588) Protein electrophoresis panel - Serum or Plasma
15
103
1.45
0.63
1.2
2.3
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
0
20
0.00
0.60
0.0
1.6
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
8
51
1.56
0.60
1.7
1.5
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
0
21
0.00
0.60
0.0
1.5
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
44
360
1.22
0.60
1.5
1.7
ug/l
0.4
0.6
2.96
33
126
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
224
2071
1.10
0.58
3.6
4.0
—
—
—
0
0
(3032352) Blasts [#/volume] in Cerebral spinal fluid
0
23
0.00
0.58
0.0
6.6
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
8
53
1.50
0.58
1.1
1.4
—
—
—
0
0
(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay
10
64
1.56
0.57
1.1
1.1
%
76.5
92.7
—
10
59
(3051611) Lipemic interference index of Serum or Plasma
8
54
1.47
0.57
4.3
3.8
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
6
36
1.66
0.56
1.3
3.6
u/ml
348.8
836.4
—
6
36
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
190
1746
1.11
0.56
3.3
2.9
—
—
—
0
0
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
8
121
0.65
0.55
1.4
2.3
mg/l
7.3
9.2
—
8
114
(3025159) Blasts/100 leukocytes in Blood
41
337
1.22
0.54
5.0
4.7
%
0.0
0.0
0.74
11
81
(40765089) Chromosome analysis panel - Blood by G-banded
11
73
1.50
0.54
1.0
1.0
—
—
—
0
0
(4010399)
33
265
1.24
0.54
1.4
1.4
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
51
429
1.19
0.54
3.6
3.2
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
9
60
1.49
0.54
1.3
1.1
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
610
5926
1.13
0.54
17.4
11.1
%
40.8
41.1
0.67
519
5222
(3035320) C reactive protein [Mass/volume] in Body fluid
6
38
1.57
0.54
1.8
1.9
—
—
—
0
0
(3024932) HLA-DR beta [Type]
6
38
1.57
0.54
1.0
1.1
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
12
168
0.70
0.53
1.0
1.1
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
6
39
1.53
0.52
1.3
1.6
—
—
—
0
0
(3024471) HLA-A [Type]
6
39
1.53
0.52
1.0
1.0
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
9
64
1.40
0.51
1.6
1.3
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
42
350
1.20
0.50
5.2
4.6
%
0.0
0.1
2.16
13
95
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
16
118
1.35
0.48
7.5
4.6
%
53.8
53.6
0.02
16
118
(3048929) Epstein Barr virus Ab [Presence] in Serum
64
556
1.15
0.48
1.5
1.5
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
7
47
1.48
0.47
4.1
4.1
—
—
—
0
0
(1002224) Polysomnography panel
30
243
1.23
0.47
1.1
1.1
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
7
48
1.45
0.46
1.1
1.2
—
—
—
0
0
(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
12
163
0.72
0.46
1.2
1.4
ug/l
12.4
5.0
0.38
12
152
(4035726)
32
262
1.22
0.46
1.4
1.6
—
—
—
0
0
(3041806) Other cells [#/volume] in Blood by Manual count
5
83
0.59
0.46
1.2
1.6
—
—
—
0
0
(4062490)
12
85
1.41
0.45
1.0
1.4
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
166
1535
1.09
0.44
1.7
1.8
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
5
31
1.60
0.43
1.2
3.1
—
—
—
0
0
(3000492) Spirometry study
51
577
0.87
0.42
1.4
1.3
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
11
78
1.40
0.41
1.6
2.0
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
39
330
1.18
0.41
3.7
1.8
e9/l
4.4
4.1
0.35
31
296
(4211845)
0
15
0.00
0.41
0.0
2.2
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
0
15
0.00
0.41
0.0
3.2
—
—
—
0
0
(3027653) Mycophenolate [Mass/volume] in Serum or Plasma
5
33
1.50
0.41
4.6
9.7
mg/l
1.3
2.9
—
5
28
(3041082) Glomerular basement membrane Ab [Titer] in Serum by Immunofluorescence
0
17
0.00
0.40
0.0
1.5
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
0
18
0.00
0.40
0.0
4.4
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
0
18
0.00
0.40
0.0
4.4
—
—
—
0
0
(3036048) Francisella tularensis Ab [Titer] in Serum
0
19
0.00
0.39
0.0
1.0
—
—
—
0
0
(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma
0
19
0.00
0.39
0.0
1.1
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
141
1303
1.09
0.38
5.4
4.8
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
5
36
1.38
0.38
1.0
1.0
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
10
71
1.40
0.37
1.2
1.1
—
—
—
0
0
(4034850)
15
115
1.30
0.37
10.3
8.1
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
5
75
0.66
0.36
1.2
1.4
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
5
76
0.65
0.36
2.2
3.1
—
—
—
0
0
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
16
199
0.79
0.35
1.1
1.1
—
8.7
—
0
12
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
10
72
1.38
0.35
1.1
1.1
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
11
81
1.35
0.34
1.0
1.4
—
—
—
0
0
(3007930) Methemoglobin/Hemoglobin.total in Blood
6
89
0.67
0.33
4.8
9.0
%
1.1
0.9
—
6
79
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
7
52
1.34
0.31
5.3
3.9
umol/l
22.9
25.2
—
7
52
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
7
96
0.72
0.31
1.3
1.3
—
—
—
0
0
(21494815) CD4 cells/100 lymphocytes in Specimen
8
105
0.75
0.29
1.4
3.4
—
50.0
—
0
9
(3037121) Protein [Mass/volume] in Urine
27
230
1.17
0.29
5.4
7.1
g/l
0.1
0.3
—
10
163
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
17
138
1.23
0.28
1.1
1.2
—
—
—
0
0
(3022145) Colonoscopy Study observation
49
437
1.12
0.28
1.3
1.5
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
25
288
0.86
0.28
1.4
1.3
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
5
73
0.68
0.26
1.2
1.7
—
—
—
0
0
(4094501)
5
74
0.67
0.26
1.0
1.1
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
21
243
0.85
0.25
1.4
1.5
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
173
1790
0.94
0.25
1.6
1.6
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
12
146
0.81
0.24
1.6
1.5
—
—
—
0
0
(3030981) Hyaline casts [#/volume] in Urine by Automated count
22
188
1.16
0.23
2.3
3.8
e6/l
0.2
0.1
0.31
22
180
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
7
92
0.75
0.22
1.4
3.1
—
745.5
—
0
25
(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum
5
40
1.24
0.22
1.4
3.8
ug/l
31.3
621.0
—
5
35
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
27
302
0.88
0.22
1.2
1.2
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
0
10
0.00
0.21
0.0
1.5
—
7.3
—
0
10
(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
0
10
0.00
0.21
0.0
1.5
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
0
10
0.00
0.21
0.0
7.0
—
—
—
0
0
(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
21
238
0.87
0.21
1.4
1.4
—
—
—
0
0
(3007302) Hemoglobin [Mass/volume] in Mixed venous blood
0
13
0.00
0.20
0.0
1.8
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
0
14
0.00
0.20
0.0
1.3
—
—
—
0
0
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3030313) Adrenal Ab [Titer] in Serum
0
14
0.00
0.20
0.0
1.4
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
0
14
0.00
0.20
0.0
2.3
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
6
49
1.21
0.20
1.2
1.2
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
21
237
0.87
0.20
1.3
1.4
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
6
50
1.19
0.19
1.2
1.2
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
240
2312
1.04
0.19
2.0
1.8
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
12
99
1.20
0.18
1.0
1.1
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
14
118
1.18
0.17
8.4
4.2
e9/l
3.7
3.7
0.00
14
118
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
5
67
0.74
0.17
1.8
2.7
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
5
69
0.72
0.17
1.0
1.2
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
84
793
1.06
0.15
1.7
1.5
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
7
86
0.80
0.14
1.3
2.0
—
—
—
0
0
(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma
7
86
0.80
0.14
1.4
1.3
pmol/l
48.4
46.9
—
7
80
(3003888) Timothy IgE Ab [Units/volume] in Serum
37
341
1.08
0.13
1.2
1.2
u/ml
5.3
8.7
0.51
29
243
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
12
103
1.16
0.12
4.4
4.8
u/ml
2.1
5.2
1.48
12
95
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
10
85
1.17
0.11
1.5
2.0
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
36
335
1.07
0.11
1.2
1.2
u/ml
1.5
1.4
0.05
25
215
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
5
47
1.05
0.09
1.0
1.1
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
16
174
0.91
0.09
1.1
1.1
—
—
—
0
0
(3010375) cycloSPORINE [Mass/volume] in Blood
6
55
1.08
0.08
42.0
34.2
ug/l
135.5
136.3
—
6
49
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
6
57
1.04
0.08
1.2
1.4
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
10
112
0.88
0.08
1.0
1.1
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
5
64
0.77
0.08
1.4
1.5
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
5
64
0.77
0.08
1.0
1.1
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
12
132
0.90
0.08
1.3
2.0
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
7
84
0.82
0.07
1.3
1.9
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
9
88
1.01
0.07
1.3
3.7
—
—
—
0
0
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
8
90
0.88
0.07
4.0
9.0
%
1.4
1.4
—
8
79
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
14
150
0.92
0.05
1.1
4.6
ug/l
1.9
6.0
—
6
110
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
39
372
1.04
0.05
1.2
1.2
u/ml
1.1
2.3
0.63
25
222
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
11
99
1.10
0.05
1.4
1.9
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
11
119
0.91
0.05
1.0
1.2
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
12
129
0.92
0.05
1.3
1.9
—
—
—
0
0
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
21
197
1.06
0.04
1.1
1.1
u/ml
0.0
0.6
—
10
77
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
22
207
1.05
0.04
1.4
1.5
—
300.0
—
0
6
(3023430) Cat dander IgE Ab [Units/volume] in Serum
22
207
1.05
0.04
1.1
1.1
u/ml
13.4
7.3
0.52
16
114
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
19
178
1.06
0.04
1.1
1.1
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
11
100
1.09
0.04
2.9
2.6
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
11
100
1.09
0.04
1.1
1.4
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
21
218
0.95
0.03
1.6
1.9
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
13
137
0.94
0.03
1.5
2.0
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
13
137
0.94
0.03
1.7
1.7
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
139
1364
1.01
0.02
2.6
2.7
—
—
—
0
0
(3010726) Horse dander IgE Ab [Units/volume] in Serum
34
329
1.03
0.01
1.2
1.2
u/ml
2.6
3.7
0.33
15
104
(3024891) Influenza virus A+B Ag [Presence] in Specimen
26
265
0.97
0.01
1.0
1.1
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
16
165
0.96
0.01
1.1
1.2
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
126
1254
0.99
0.00
1.9
1.8
—
—
—
0
0
(3014133) Dog dander IgE Ab [Units/volume] in Serum
23
227
1.00
0.00
1.1
1.1
u/ml
4.1
7.0
0.85
14
119
(3014599) Egg white IgE Ab [Units/volume] in Serum
12
117
1.02
0.00
1.1
1.4
u/ml
0.5
6.8
—
7
64
(3008898) HLA-B27 [Presence]
34
339
0.99
0.00
1.0
1.1
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
11
104
1.05
0.00
1.0
1.1
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
12
122
0.97
0.00
1.3
1.9
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
35
346
1.00
0.00
1.2
1.3
miu/ml
278.4
254.6
—
8
166
(3017569) Oxygen content in Arterial blood
0
8
0.00
0.00
0.0
9.6
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
5
55
0.90
0.00
1.8
1.2
—
—
—
0
0
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
0
5
0.00
0.00
0.0
5.0
—
0.2
—
0
5
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
0
6
0.00
0.00
0.0
1.2
—
1.8
—
0
6
(3014591) Smooth Alder IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(40760512) CD34 cells/100 cells in Bone marrow
0
7
0.00
0.00
0.0
2.1
—
—
—
0
0
(3027570) Oxalate [Moles/time] in 24 hour Urine
0
7
0.00
0.00
0.0
1.0
—
288.3
—
0
7
(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture
0
8
0.00
0.00
0.0
2.0
—
—
—
0
0
(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3007733) Chloride [Moles/volume] in Urine
0
5
0.00
0.00
0.0
2.4
—
89.4
—
0
5
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
0
5
0.00
0.00
0.0
11.2
—
—
—
0
0
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3008860) Bordetella pertussis IgM Ab [Presence] in Serum
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(40763590) HLA-DQ beta [Type]
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(46236302) HLA-C [Type] by High resolution typing
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013862) HLA-DP [Type]
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(44813793)
6
66
0.90
0.00
1.3
1.1
—
—
—
0
0
(3020356) Listeria sp identified in Specimen by Organism specific culture
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3010937) Rubella virus Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3051252) Vasoactive intestinal peptide [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.0
—
15.2
—
0
5
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3038702) Sodium [Moles/volume] in Capillary blood
0
5
0.00
0.00
0.0
4.2
—
140.0
—
0
5
(44806071)
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
7
70
0.99
0.00
2.6
1.5
—
—
—
0
0
(3040893) Potassium [Moles/volume] in Capillary blood
0
8
0.00
0.00
0.0
5.5
—
4.5
—
0
8
(3045424) Erythrocytes [Presence] in Urine
6
68
0.87
0.00
1.5
1.3
—
—
—
0
0
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.6
—
148.0
—
0
5
(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count
0
5
0.00
0.00
0.0
2.4
—
—
—
0
0
(40760410) HLA-B [Type] by High resolution
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40760409) HLA-A [Type] by High resolution
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
5
52
0.95
0.00
1.2
1.4
nmol/l
—
—
—
0
0
(40768793) Breast Pathology biopsy report
5
58
0.85
0.00
1.2
1.1
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
5
53
0.93
0.00
1.2
1.9
—
—
—
0
0
(3004451) EKG impression Narrative
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
7
69
1.01
0.00
2.4
2.6
ug/min
28.9
146.2
—
7
45
(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
9
94
0.95
0.00
1.6
1.3
—
—
—
0
0
(3034092) Cytoplasmic Ig cells/100 cells in Blood
0
5
0.00
0.00
0.0
2.8
—
—
—
0
0
(3019768) Coxiella burnetii Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint F5_HYPERKIN and mortality.
Females
No dataMales
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| F5_HYPERKIN | 3.079 [2.45, 3.88] | < 0.001 |
| Birth year | 0.987 [0.98, 1.0] | 0.007 |
During the follow-up period (1.1.1998 — 31.12.2019), 133 out of 11270 males with F5_HYPERKIN died.
Mortality risk
Mortality risk for people of age
years, who have F5_HYPERKIN.| N-year risk | Females | Males |
|---|---|---|
| 1 | No data | 0.595% |
| 5 | No data | 3.574% |
| 10 | No data | 8.962% |
| 15 | No data | 15.978% |
| 20 | No data | 26.045% |
Relationships between endpoints
↥Index endpoint: F5_HYPERKIN – Hyperkinetic disorders (excl. ADHD)
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data